Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage

JAMA - Journal of the American Medical Association

Volumn 313, Issue 8, 2015, Pages 824-836

  Kuramatsu, Joji B ^a   Gerner, Stefan T ^a   Schellinger, Peter D ^b   Glahn, Jörg ^b   Endres, Matthias ^c,d,e   Sobesky, Jan ^c   Flechsenhar, Julia ^c   Neugebauer, Hermann ^c,f   Jüttler, Eric ^c,f   Grau, Armin ^g   Palm, Frederick ^g   Röther, Joachim ^h   Michels, Peter ^h   Hamann, Gerhard F ⁱ   Hüwel, Joachim ⁱ   Hagemann, Georg ^j   Barber, Beatrice ^j   Terborg, Christoph ^k   Trostdorf, Frank ^k   Bäzner, Hansjörg ^l   Roth, Aletta ^l   Wöhrle, Johannes ^m   Keller, Moritz ^m   Schwarz, Michael ⁿ   Reimann, Gernot ⁿ   Volkmann, Jens ^o   Müllges, Wolfgang ^o   Kraft, Peter ^o   Classen, Joseph ^p   Hobohm, Carsten ^p   Horn, Markus ^q   Milewski, Angelika ^q   Reichmann, Heinz ^r   Schneider, Hauke ^r   Schimmel, Eik ^r   Fink, Gereon R ^s   Dohmen, Christian ^s   Stetefeld, Henning ^s   Witte, Otto ^t   Günther, Albrecht ^t   Neumann Haefelin, Tobias ^u   Racs, Andras E ^u   Nueckel, Martin ^v   Erbguth, Frank ^v   Kloska, Stephan P ^a   Dörfler, Arnd ^a   Köhrmann, Martin ^a   Schwab, Stefan ^a   Huttner, Hagen B ^a   more..

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b KLINIKUM MINDEN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Center for Stroke Research Berlin   (Germany)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^f UNIVERSITY OF ULM   (Germany)

^g KLINIKUM LUDWIGSHAFEN   (Germany)

^h MRI Institute Hamburg Altona   (Germany)

ⁱ DR HORST SCHMIDT KLINIKEN   (Germany)

^j HELIOS KLINIKUM BERLIN BUCH   (Germany)

^k DEPARTMENT OF CARDIOLOGY   (Germany)

^l KLINIKUM STUTTGART   (Germany)

^m Department of Neurology Community Hospital Klinikum Koblenz   (Germany)

ⁿ KLINIKUM DORTMUND   (Germany)

^o UNIVERSITY OF WÜRZBURG   (Germany)

^p UNIVERSITY OF LEIPZIG   (Germany)

^q Klinikum Bad Hersfeld   (Germany)

^r DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^s UNIVERSITY OF COLOGNE   (Germany)

^t FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^u KLINIKUM FULDA   (Germany)

^v Department of Neurology   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

AGED; ANTICOAGULATION; ARTICLE; BLOOD PRESSURE; BRAIN HEMORRHAGE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; GLASGOW COMA SCALE; HEART ATRIUM FIBRILLATION; HEMATOMA; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROPENSITY SCORE; RANKIN SCALE; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL; ATRIAL FIBRILLATION; BLEEDING; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPLICATION; DISEASE COURSE; DRUG EFFECTS; ISCHEMIA; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; STATISTICAL MODEL; STROKE; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; BLOOD PRESSURE; CEREBRAL HEMORRHAGE; DISEASE PROGRESSION; FEMALE; HEMATOMA; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE; TREATMENT OUTCOME;

EID: 84923314908     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.0846     Document Type: Article

References (40)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370-2375.
2. Patel NJ, Deshmukh A, Pant S, et al. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning. Circulation. 2014;129(23):2371-2379.
3. Masotti L, Di NapoliM, Godoy DA, et al. The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy. Int J Stroke. 2011;6(3):228-240.
4. Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003;349(11):1019-1026.
5. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. 2004;164(8):880-884.
6. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J.Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63(6):1059-1064.
7. Flaherty ML, Tao H, Haverbusch M, et al. Warfarin use leads to larger intracerebral hematomas. Neurology. 2008;71(14):1084-1089.
8. Cervera A, Amaro S, Chamorro A. Oral anticoagulant-associated intracerebral hemorrhage. J Neurol. 2012;259(2):212-224.
9. Morgenstern LB, Hemphill JC III, Anderson C, et al American Heart Association Stroke Council and Council on Cardiovascular Nursing. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41(9):2108-2129.
10. Steiner T, Al-Shahi Salman R, Beer R, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke. 2014;9(7):840-855.
11. Poli D, Antonucci E, Dentali F, et al Italian Federation of Anticoagulation Clinics (FCSA). Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE study. Neurology. 2014;82(12):1020-1026.
12. Majeed A, Kim YK, Roberts RS, HolmströmM, Schulman S. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke. 2010;41(12):2860-2866.
13. Gage BF,Waterman AD, ShannonW, Boechler M, RichMW, RadfordMJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864-2870.
14. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093-1100.
15. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28(1):1-5.
16. Qureshi AI, Palesch YY, Martin R, et al Antihypertensive Treatment of Acute Cerebral Hemorrhage Study Investigators. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Arch Neurol. 2010;67(5):570-576.
17. Demchuk AM, Dowlatshahi D, Rodriguez-Luna D, et al; PREDICT/Sunnybrook ICH CTA study group. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol. 2012;11(4):307-314.
18. Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27(8):1304-1305.
19. Huttner HB, Steiner T, Hartmann M, et al. Comparison of ABC/2 estimation technique to computer-assisted planimetric analysis in warfarin-related intracerebral parenchymal hemorrhage. Stroke. 2006;37(2):404-408.
20. Burgess RE,Warach S, Schaewe TJ, et al. Development and validation of a simple conversion model for comparison of intracerebral hemorrhage volumes measured on CT and gradient recalled echo MRI. Stroke. 2008;39(7):2017-2020.
21. Graeb DA, Robertson WD, Lapointe JS, Nugent RA, Harrison PB. Computed tomographic diagnosis of intraventricular hemorrhage: etiology and prognosis. Radiology. 1982;143(1):91-96.
22. Sarode R, Milling TJ Jr, Refaai MA, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128(11):1234-1243.
23. Connolly SJ, Ezekowitz MD, Yusuf S, et al RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139-1151.
24. Zubkov AY, Mandrekar JN, Claassen DO, Manno EM, Wijdicks EF, Rabinstein AA. Predictors of outcome in warfarin-related intracerebral hemorrhage. Arch Neurol. 2008;65(10):1320-1325.
25. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39(4):561-577.
26. HackeW, Donnan G, Fieschi C, et al ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363(9411):768-774.
27. Steiner SH, JonesM. Risk-adjusted survival time monitoring with an updating exponentially weighted moving average (EWMA) control chart. Stat Med. 2010;29(4):444-454.
28. Rassen JA, Shelat AA,Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012;21(suppl 2):69-80.
29. Groenwold RH, Donders AR, Roes KC, Harrell FE Jr, Moons KG. Dealing with missing outcome data in randomized trials and observational studies. Am J Epidemiol. 2012;175(3):210-217.
30. Yung D, Kapral MK, Asllani E, Fang J, Lee DS; Investigators of the Registry of the Canadian Stroke Network. Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: the Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study. Can J Cardiol. 2012;28(1):33-39.
31. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344(19):1450-1460.
32. Anderson CS, Heeley E, Huang Y, et al; INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355-2365.
33. Mayer SA, Brun NC, Begtrup K, et al FAST Trial Investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358(20):2127-2137.
34. Huttner HB, Schellinger PD, Hartmann M, et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke. 2006;37(6):1465-1470.
35. Holbrook A, Schulman S, Witt DM, et al American College of Chest Physicians. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2)(suppl):e152S-e184S.
36. Bailey RD, Hart RG, Benavente O, Pearce LA. Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology. 2001;56(6):773-777.
37. Avgil Tsadok M, Jackevicius CA, Rahme E, Humphries KH, Behlouli H, Pilote L. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. JAMA. 2012;307(18):1952-1958.
38. Chatterjee S, Sardar P, Biondi-Zoccai G, Kumbhani DJ. New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation. JAMA Neurol. 2013;70(12):1486-1490.
39. Becker KJ, Baxter AB, CohenWA, et al. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology. 2001;56(6):766-772.
40. Steiner LA, Andrews PJ. Monitoring the injured brain: ICP and CBF. Br J Anaesth. 2006;97(1):26-38.